Visible pigmentation remains for 48 weeks post-dosing as melanin-containing keratinocytes turn over
2010 Apr;15(1):76-83
A biotech company called Kariya Pharmaceticals is developing a drug called KP405 , which combines a GLP-1 receptor agonist with a glucose-dependent insulinotropic peptide (or GIP) agonist
In markets like Germany, France, and the Nordics, where both obesity and proactive health trends are high, there is strong potential for targeted NPD and retailer-led innovation. Nestls Vital Pursuit, a portion-controlled, nutrient-filled frozen food line spanning pizzas and sandwich melts to wholegrain bowls, launched in 2024 to support GLP-1 users in the United States
Now, 29 states and Washington, D.C., have some form of medical marijuana laws on the books that run counter to federal law, the Marijuana Policy Project notes